NCT03890718

Brief Summary

To our knowledge, this study is one of the first to compare the visual results of non-topography-guided and topography-guided photorefractive keratectomy (PRK) applying sequential and simultaneous corneal cross-linking (CXL) treatment for keratoconus. Considering recent advances in cross-linking and imaging in keratoconus, the outcomes of this study can lead us to several non-invasive algorithm management options.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2017

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

March 25, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 26, 2019

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
Last Updated

April 18, 2022

Status Verified

January 1, 2022

Enrollment Period

5.5 years

First QC Date

March 25, 2019

Last Update Submit

April 10, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • visual acuity

    Visual acuity (VA) commonly refers to the clarity of vision

    3 months

Other Outcomes (1)

  • Aberrometry properties by iTrace Ray-tracing aberrometry

    3 year

Study Arms (1)

Photorefractive keratectomy in mile keratoconus

EXPERIMENTAL

Photorefractive keratectomy in mile keratoconus type of corneal surface ablation in for correct refractive error

Procedure: Photorefractive keratectomy in mile keratoconus

Interventions

Topo-guided photorefractive keratectomy will be performed using an excimer laser (Allegretto Wave Topolyzer, Alcon, Inc.) with a 6 mm optical area and a transition area of 2 mm in all eyes. At that point, the partial topography-guided photorefractive keratectomy laser treatment will be finished. The arrangement will be to treat 70% of the cylindrical and spherical part to not surpass 50μm of stromal expulsion. The estimation of 50μm as the most extreme removal depth recommended by Kanellopoulos in Athens protocol will be chosen

Also known as: Advance surface abelation in mild keratoconus
Photorefractive keratectomy in mile keratoconus

Eligibility Criteria

Age34 Years - 41 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age 34 (range from 34 to 41)
  • stable corneal topography and refraction for at least six months
  • estimated residual bed thickness of \>410 µm

You may not qualify if:

  • presence of macular or retinal disease,
  • dry eye
  • history of recurrent corneal erosions
  • anterior segment abnormalities
  • unstable refractive error
  • post-surgically residual stromal bed thickness of under 350 mm
  • autoimmune disease
  • collagen vascular disease
  • immunosuppressive therapy or current use of systemic corticosteroids
  • diabetes mellitus
  • pregnancy
  • lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Farideh Doroodgar

Tehran, Iran

Location

MeSH Terms

Conditions

Keratoconus

Interventions

Photorefractive Keratectomy

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Corneal Surgery, LaserLaser TherapyTherapeuticsAblation TechniquesSurgical Procedures, OperativeKeratectomyRefractive Surgical ProceduresOphthalmologic Surgical Procedures

Study Officials

  • Jorge Alio, MD,PhD

    Division of Ophthalmology, Universidad Miguel Hernández, Alicante, Spain

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophthalmologist

Study Record Dates

First Submitted

March 25, 2019

First Posted

March 26, 2019

Study Start

March 30, 2017

Primary Completion

September 30, 2022

Study Completion

December 15, 2023

Last Updated

April 18, 2022

Record last verified: 2022-01

Locations